## Core Concept
Hepatic adenomas, also known as hepatocellular adenomas, are rare, benign liver tumors often associated with oral contraceptive use, anabolic steroid use, and certain metabolic disorders. They are composed of hepatocytes and have a risk of rupture and bleeding. The management and characteristics of these tumors are critical for understanding their clinical implications.

## Why the Correct Answer is Right
To accurately assess which statement is false about hepatic adenoma, the specific details of each option (A, B, C, D) are required. However, generally, hepatic adenomas are known for their association with hormonal influences (like oral contraceptives), potential for rupture and hemorrhage, and their classification into different subtypes based on molecular and pathological features. Without the specific options provided, we can infer that a false statement might contradict established knowledge such as their typical imaging characteristics (e.g., hypervascular on imaging), association with specific risk factors, or their malignant potential.

## Why Each Wrong Option is Incorrect
- **Option A:** Without specifics, we can't directly address why an option is incorrect, but if an option suggests hepatic adenomas are malignant, it would be incorrect because they are typically benign.
- **Option B:** Similarly, if an option denies the association with oral contraceptives or anabolic steroids, it would be incorrect because these are well-established risk factors.
- **Option C:** If an option inaccurately describes the typical presentation or management strategy, it would be incorrect based on current clinical guidelines.
- **Option D:** This option would presumably offer another incorrect statement about hepatic adenomas.

## Clinical Pearl / High-Yield Fact
A key point to remember is that hepatic adenomas are often associated with **oral contraceptive use** and have a risk of **rupture and bleeding**. They are usually **hypervascular** on imaging studies. A critical clinical consideration is the management strategy, which may include discontinuation of oral contraceptives, surgical resection, or other interventions based on size, symptoms, and risk factors.

## Correct Answer: D.